OXOID LIMITED

Oxoid Limited manufactures in vitro diagnostic (IVD) products for microbiological testing, including culture media supplements, antimicrobial susceptibility testing discs, and serological reagents for identifying bacterial species and toxins. Their portfolio also includes fluorescent immunoassay kits for detecting respiratory viruses, such as parainfluenza and influenza, as well as atmospheric generation kits and software tools for automated identification of bacterial isolates.

The company’s devices are classified under FDA’s Class I and Class II regulatory categories and are listed in the FDA’s Unique Device Identifier (UDI) database. Oxoid Limited operates from the United States, adhering to applicable IVD regulations for diagnostic testing products.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.